Epithelial-Mesenchymal Transition, human (Scheel, 2011): : averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXO3
|
ENSG00000118689.10 | FOXO3 |
FOXD2
|
ENSG00000186564.5 | FOXD2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXO3 | hg19_v2_chr6_+_108977520_108977549 | -0.88 | 4.4e-03 | Click! |
FOXD2 | hg19_v2_chr1_+_47901689_47901689 | 0.34 | 4.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_31497271 | 4.78 |
ENST00000520407.1 |
NRG1 |
neuregulin 1 |
chr2_-_165424973 | 3.52 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chr8_+_95653373 | 2.42 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr8_+_95653302 | 2.41 |
ENST00000423620.2 ENST00000433389.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr6_-_136847099 | 2.33 |
ENST00000438100.2 |
MAP7 |
microtubule-associated protein 7 |
chr6_+_125540951 | 2.21 |
ENST00000524679.1 |
TPD52L1 |
tumor protein D52-like 1 |
chr11_+_10476851 | 2.01 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr1_+_84630367 | 2.00 |
ENST00000370680.1 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr6_-_136847610 | 1.97 |
ENST00000454590.1 ENST00000432797.2 |
MAP7 |
microtubule-associated protein 7 |
chr11_-_108464465 | 1.68 |
ENST00000525344.1 |
EXPH5 |
exophilin 5 |
chr6_-_136788001 | 1.68 |
ENST00000544465.1 |
MAP7 |
microtubule-associated protein 7 |
chr12_-_28124903 | 1.64 |
ENST00000395872.1 ENST00000354417.3 ENST00000201015.4 |
PTHLH |
parathyroid hormone-like hormone |
chr2_+_163175394 | 1.63 |
ENST00000446271.1 ENST00000429691.2 |
GCA |
grancalcin, EF-hand calcium binding protein |
chr12_-_28123206 | 1.62 |
ENST00000542963.1 ENST00000535992.1 |
PTHLH |
parathyroid hormone-like hormone |
chr11_-_108464321 | 1.59 |
ENST00000265843.4 |
EXPH5 |
exophilin 5 |
chr8_-_127570603 | 1.55 |
ENST00000304916.3 |
FAM84B |
family with sequence similarity 84, member B |
chr12_-_28122980 | 1.52 |
ENST00000395868.3 ENST00000534890.1 |
PTHLH |
parathyroid hormone-like hormone |
chr1_-_12677714 | 1.46 |
ENST00000376223.2 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
chr3_-_190167571 | 1.43 |
ENST00000354905.2 |
TMEM207 |
transmembrane protein 207 |
chr11_-_115375107 | 1.29 |
ENST00000545380.1 ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1 |
cell adhesion molecule 1 |
chr12_-_31479045 | 1.28 |
ENST00000539409.1 ENST00000395766.1 |
FAM60A |
family with sequence similarity 60, member A |
chr8_-_134309823 | 1.26 |
ENST00000414097.2 |
NDRG1 |
N-myc downstream regulated 1 |
chr8_-_134309335 | 1.25 |
ENST00000522890.1 ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1 |
N-myc downstream regulated 1 |
chr8_-_80993010 | 1.23 |
ENST00000537855.1 ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52 |
tumor protein D52 |
chr12_-_53343602 | 1.20 |
ENST00000546897.1 ENST00000552551.1 |
KRT8 |
keratin 8 |
chr11_-_72504681 | 1.18 |
ENST00000538536.1 ENST00000543304.1 ENST00000540587.1 ENST00000334805.6 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
chr8_+_31496809 | 1.17 |
ENST00000518104.1 ENST00000519301.1 |
NRG1 |
neuregulin 1 |
chr10_-_45474237 | 1.16 |
ENST00000448778.1 ENST00000298295.3 |
C10orf10 |
chromosome 10 open reading frame 10 |
chr17_-_46657473 | 1.15 |
ENST00000332503.5 |
HOXB4 |
homeobox B4 |
chr5_+_140186647 | 1.12 |
ENST00000512229.2 ENST00000356878.4 ENST00000530339.1 |
PCDHA4 |
protocadherin alpha 4 |
chr20_+_58251716 | 1.12 |
ENST00000355648.4 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr7_-_105332084 | 1.11 |
ENST00000472195.1 |
ATXN7L1 |
ataxin 7-like 1 |
chr20_+_58179582 | 1.09 |
ENST00000371015.1 ENST00000395639.4 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr17_+_38333263 | 1.08 |
ENST00000456989.2 ENST00000543876.1 ENST00000544503.1 ENST00000264644.6 ENST00000538884.1 |
RAPGEFL1 |
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr12_-_31479107 | 1.06 |
ENST00000542983.1 |
FAM60A |
family with sequence similarity 60, member A |
chr7_-_41742697 | 1.04 |
ENST00000242208.4 |
INHBA |
inhibin, beta A |
chr2_+_27665232 | 1.01 |
ENST00000543753.1 ENST00000288873.3 |
KRTCAP3 |
keratinocyte associated protein 3 |
chr12_-_28125638 | 0.98 |
ENST00000545234.1 |
PTHLH |
parathyroid hormone-like hormone |
chr2_-_69098566 | 0.98 |
ENST00000295379.1 |
BMP10 |
bone morphogenetic protein 10 |
chr2_+_27665289 | 0.96 |
ENST00000407293.1 |
KRTCAP3 |
keratinocyte associated protein 3 |
chr8_-_28243934 | 0.94 |
ENST00000521185.1 ENST00000520290.1 ENST00000344423.5 |
ZNF395 |
zinc finger protein 395 |
chr8_+_99956759 | 0.93 |
ENST00000522510.1 ENST00000457907.2 |
OSR2 |
odd-skipped related transciption factor 2 |
chr8_-_29208183 | 0.92 |
ENST00000240100.2 |
DUSP4 |
dual specificity phosphatase 4 |
chr7_-_37026108 | 0.89 |
ENST00000396045.3 |
ELMO1 |
engulfment and cell motility 1 |
chr13_-_41240717 | 0.88 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr21_-_42219065 | 0.87 |
ENST00000400454.1 |
DSCAM |
Down syndrome cell adhesion molecule |
chr19_+_45844018 | 0.87 |
ENST00000585434.1 |
KLC3 |
kinesin light chain 3 |
chr12_-_123187890 | 0.86 |
ENST00000328880.5 |
HCAR2 |
hydroxycarboxylic acid receptor 2 |
chr1_+_24646002 | 0.85 |
ENST00000356046.2 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr4_-_123542224 | 0.84 |
ENST00000264497.3 |
IL21 |
interleukin 21 |
chr5_+_140220769 | 0.83 |
ENST00000531613.1 ENST00000378123.3 |
PCDHA8 |
protocadherin alpha 8 |
chr1_+_24645865 | 0.81 |
ENST00000342072.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr1_+_24645807 | 0.81 |
ENST00000361548.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chrX_-_133792480 | 0.81 |
ENST00000359237.4 |
PLAC1 |
placenta-specific 1 |
chr5_-_38557561 | 0.79 |
ENST00000511561.1 |
LIFR |
leukemia inhibitory factor receptor alpha |
chr5_+_147258266 | 0.79 |
ENST00000296694.4 |
SCGB3A2 |
secretoglobin, family 3A, member 2 |
chr18_+_60382672 | 0.78 |
ENST00000400316.4 ENST00000262719.5 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
chr17_+_72426891 | 0.77 |
ENST00000392627.1 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr2_-_69180083 | 0.77 |
ENST00000328895.4 |
GKN2 |
gastrokine 2 |
chr16_-_57831914 | 0.77 |
ENST00000421376.2 |
KIFC3 |
kinesin family member C3 |
chr6_-_42418999 | 0.75 |
ENST00000340840.2 ENST00000354325.2 |
TRERF1 |
transcriptional regulating factor 1 |
chr4_+_15376165 | 0.75 |
ENST00000382383.3 ENST00000429690.1 |
C1QTNF7 |
C1q and tumor necrosis factor related protein 7 |
chr1_-_117210290 | 0.75 |
ENST00000369483.1 ENST00000369486.3 |
IGSF3 |
immunoglobulin superfamily, member 3 |
chr3_-_151034734 | 0.74 |
ENST00000260843.4 |
GPR87 |
G protein-coupled receptor 87 |
chr18_+_61254534 | 0.74 |
ENST00000269489.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr20_+_58630972 | 0.74 |
ENST00000313426.1 |
C20orf197 |
chromosome 20 open reading frame 197 |
chr11_-_34535297 | 0.74 |
ENST00000532417.1 |
ELF5 |
E74-like factor 5 (ets domain transcription factor) |
chr14_+_61788429 | 0.73 |
ENST00000332981.5 |
PRKCH |
protein kinase C, eta |
chr5_-_115872142 | 0.73 |
ENST00000510263.1 |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr2_-_69180012 | 0.73 |
ENST00000481498.1 |
GKN2 |
gastrokine 2 |
chr14_-_91526922 | 0.72 |
ENST00000418736.2 ENST00000261991.3 |
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr7_-_27135591 | 0.72 |
ENST00000343060.4 ENST00000355633.5 |
HOXA1 |
homeobox A1 |
chr1_+_152486950 | 0.72 |
ENST00000368790.3 |
CRCT1 |
cysteine-rich C-terminal 1 |
chr17_-_77925806 | 0.71 |
ENST00000574241.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr14_-_21493649 | 0.71 |
ENST00000553442.1 ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2 |
NDRG family member 2 |
chr2_-_71454185 | 0.68 |
ENST00000244221.8 |
PAIP2B |
poly(A) binding protein interacting protein 2B |
chr1_-_217250231 | 0.68 |
ENST00000493748.1 ENST00000463665.1 |
ESRRG |
estrogen-related receptor gamma |
chr3_-_33700589 | 0.67 |
ENST00000461133.3 ENST00000496954.2 |
CLASP2 |
cytoplasmic linker associated protein 2 |
chr7_-_140340576 | 0.67 |
ENST00000275884.6 ENST00000475837.1 |
DENND2A |
DENN/MADD domain containing 2A |
chr20_+_52105495 | 0.66 |
ENST00000439873.2 |
AL354993.1 |
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
chr2_+_17721920 | 0.66 |
ENST00000295156.4 |
VSNL1 |
visinin-like 1 |
chr4_-_74486217 | 0.66 |
ENST00000335049.5 ENST00000307439.5 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr5_+_36608422 | 0.64 |
ENST00000381918.3 |
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr13_-_46716969 | 0.64 |
ENST00000435666.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr6_+_32121789 | 0.64 |
ENST00000437001.2 ENST00000375137.2 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr6_+_32121908 | 0.64 |
ENST00000375143.2 ENST00000424499.1 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr7_-_121944491 | 0.63 |
ENST00000331178.4 ENST00000427185.2 ENST00000442488.2 |
FEZF1 |
FEZ family zinc finger 1 |
chr18_+_55816546 | 0.61 |
ENST00000435432.2 ENST00000357895.5 ENST00000586263.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr18_-_53070913 | 0.61 |
ENST00000568186.1 ENST00000564228.1 |
TCF4 |
transcription factor 4 |
chr8_-_40755333 | 0.60 |
ENST00000297737.6 ENST00000315769.7 |
ZMAT4 |
zinc finger, matrin-type 4 |
chr2_-_27435125 | 0.60 |
ENST00000414408.1 ENST00000310574.3 |
SLC5A6 |
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
chr7_+_134832808 | 0.59 |
ENST00000275767.3 |
TMEM140 |
transmembrane protein 140 |
chr18_-_53303123 | 0.59 |
ENST00000569357.1 ENST00000565124.1 ENST00000398339.1 |
TCF4 |
transcription factor 4 |
chr18_+_61254570 | 0.59 |
ENST00000344731.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr17_-_39942940 | 0.58 |
ENST00000310706.5 ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP |
junction plakoglobin |
chr14_-_21493884 | 0.58 |
ENST00000556974.1 ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2 |
NDRG family member 2 |
chr12_-_123201337 | 0.57 |
ENST00000528880.2 |
HCAR3 |
hydroxycarboxylic acid receptor 3 |
chr3_-_33700933 | 0.57 |
ENST00000480013.1 |
CLASP2 |
cytoplasmic linker associated protein 2 |
chr7_-_140624499 | 0.57 |
ENST00000288602.6 |
BRAF |
v-raf murine sarcoma viral oncogene homolog B |
chr1_-_207095324 | 0.56 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr1_+_120839412 | 0.55 |
ENST00000355228.4 |
FAM72B |
family with sequence similarity 72, member B |
chr6_+_12290586 | 0.55 |
ENST00000379375.5 |
EDN1 |
endothelin 1 |
chr1_-_28503693 | 0.55 |
ENST00000373857.3 |
PTAFR |
platelet-activating factor receptor |
chr10_+_71561649 | 0.55 |
ENST00000398978.3 ENST00000354547.3 ENST00000357811.3 |
COL13A1 |
collagen, type XIII, alpha 1 |
chr14_-_31926623 | 0.54 |
ENST00000356180.4 |
DTD2 |
D-tyrosyl-tRNA deacylase 2 (putative) |
chr10_+_24738355 | 0.54 |
ENST00000307544.6 |
KIAA1217 |
KIAA1217 |
chr14_-_23288930 | 0.54 |
ENST00000554517.1 ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr12_-_86650045 | 0.54 |
ENST00000604798.1 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr18_-_53257027 | 0.53 |
ENST00000568740.1 ENST00000564403.2 ENST00000537578.1 |
TCF4 |
transcription factor 4 |
chr21_+_39628852 | 0.53 |
ENST00000398938.2 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr22_+_43506747 | 0.53 |
ENST00000216115.2 |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
chr1_+_86934526 | 0.53 |
ENST00000394711.1 |
CLCA1 |
chloride channel accessory 1 |
chr14_-_31926701 | 0.53 |
ENST00000310850.4 |
DTD2 |
D-tyrosyl-tRNA deacylase 2 (putative) |
chr8_+_26150628 | 0.53 |
ENST00000523925.1 ENST00000315985.7 |
PPP2R2A |
protein phosphatase 2, regulatory subunit B, alpha |
chr1_-_153514241 | 0.52 |
ENST00000368718.1 ENST00000359215.1 |
S100A5 |
S100 calcium binding protein A5 |
chr2_+_26785409 | 0.51 |
ENST00000329615.3 ENST00000409392.1 |
C2orf70 |
chromosome 2 open reading frame 70 |
chr10_+_123923105 | 0.51 |
ENST00000368999.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr2_+_196521845 | 0.51 |
ENST00000359634.5 ENST00000412905.1 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
chr5_+_140165876 | 0.51 |
ENST00000504120.2 ENST00000394633.3 ENST00000378133.3 |
PCDHA1 |
protocadherin alpha 1 |
chr4_-_143227088 | 0.50 |
ENST00000511838.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr19_+_45844032 | 0.50 |
ENST00000589837.1 |
KLC3 |
kinesin light chain 3 |
chr2_-_160472952 | 0.50 |
ENST00000541068.2 ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B |
bromodomain adjacent to zinc finger domain, 2B |
chr20_-_22566089 | 0.50 |
ENST00000377115.4 |
FOXA2 |
forkhead box A2 |
chr1_-_26394114 | 0.49 |
ENST00000374272.3 |
TRIM63 |
tripartite motif containing 63, E3 ubiquitin protein ligase |
chr11_-_72504637 | 0.49 |
ENST00000536377.1 ENST00000359373.5 |
STARD10 ARAP1 |
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr1_-_202927490 | 0.49 |
ENST00000340990.5 |
ADIPOR1 |
adiponectin receptor 1 |
chr4_-_111119804 | 0.49 |
ENST00000394607.3 ENST00000302274.3 |
ELOVL6 |
ELOVL fatty acid elongase 6 |
chr2_+_86947296 | 0.49 |
ENST00000283632.4 |
RMND5A |
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr17_+_65374075 | 0.48 |
ENST00000581322.1 |
PITPNC1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr18_-_19994830 | 0.48 |
ENST00000525417.1 |
CTAGE1 |
cutaneous T-cell lymphoma-associated antigen 1 |
chr19_-_33360647 | 0.47 |
ENST00000590341.1 ENST00000587772.1 ENST00000023064.4 |
SLC7A9 |
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 |
chr2_-_134326009 | 0.47 |
ENST00000409261.1 ENST00000409213.1 |
NCKAP5 |
NCK-associated protein 5 |
chr6_+_1080164 | 0.46 |
ENST00000314040.1 |
AL033381.1 |
Uncharacterized protein; cDNA FLJ34594 fis, clone KIDNE2009109 |
chr2_+_113875466 | 0.45 |
ENST00000361779.3 ENST00000259206.5 ENST00000354115.2 |
IL1RN |
interleukin 1 receptor antagonist |
chr3_+_122513642 | 0.45 |
ENST00000261038.5 |
DIRC2 |
disrupted in renal carcinoma 2 |
chr6_+_134758827 | 0.45 |
ENST00000431422.1 |
LINC01010 |
long intergenic non-protein coding RNA 1010 |
chr17_+_26662597 | 0.45 |
ENST00000544907.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr7_-_25702669 | 0.45 |
ENST00000446840.1 |
AC003090.1 |
AC003090.1 |
chr5_-_16509101 | 0.44 |
ENST00000399793.2 |
FAM134B |
family with sequence similarity 134, member B |
chr7_-_16840820 | 0.44 |
ENST00000450569.1 |
AGR2 |
anterior gradient 2 |
chr10_-_99094458 | 0.44 |
ENST00000371019.2 |
FRAT2 |
frequently rearranged in advanced T-cell lymphomas 2 |
chr2_+_234959376 | 0.43 |
ENST00000425558.1 |
SPP2 |
secreted phosphoprotein 2, 24kDa |
chr13_-_86373536 | 0.43 |
ENST00000400286.2 |
SLITRK6 |
SLIT and NTRK-like family, member 6 |
chr19_+_13134772 | 0.43 |
ENST00000587760.1 ENST00000585575.1 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
chr10_+_71561630 | 0.43 |
ENST00000398974.3 ENST00000398971.3 ENST00000398968.3 ENST00000398966.3 ENST00000398964.3 ENST00000398969.3 ENST00000356340.3 ENST00000398972.3 ENST00000398973.3 |
COL13A1 |
collagen, type XIII, alpha 1 |
chr3_+_160394940 | 0.43 |
ENST00000320767.2 |
ARL14 |
ADP-ribosylation factor-like 14 |
chr16_-_57831676 | 0.43 |
ENST00000465878.2 ENST00000539578.1 ENST00000561524.1 |
KIFC3 |
kinesin family member C3 |
chr11_-_102651343 | 0.42 |
ENST00000279441.4 ENST00000539681.1 |
MMP10 |
matrix metallopeptidase 10 (stromelysin 2) |
chr12_-_71031185 | 0.42 |
ENST00000548122.1 ENST00000551525.1 ENST00000550358.1 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr1_+_227127981 | 0.42 |
ENST00000366778.1 ENST00000366777.3 ENST00000458507.2 |
ADCK3 |
aarF domain containing kinase 3 |
chr10_+_123922941 | 0.42 |
ENST00000360561.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr2_-_74669009 | 0.42 |
ENST00000272430.5 |
RTKN |
rhotekin |
chr7_+_129906660 | 0.42 |
ENST00000222481.4 |
CPA2 |
carboxypeptidase A2 (pancreatic) |
chr1_-_24469602 | 0.42 |
ENST00000270800.1 |
IL22RA1 |
interleukin 22 receptor, alpha 1 |
chr8_+_99956662 | 0.42 |
ENST00000523368.1 ENST00000297565.4 ENST00000435298.2 |
OSR2 |
odd-skipped related transciption factor 2 |
chr10_+_24755416 | 0.42 |
ENST00000396446.1 ENST00000396445.1 ENST00000376451.2 |
KIAA1217 |
KIAA1217 |
chr19_-_45909585 | 0.42 |
ENST00000593226.1 ENST00000418234.2 |
PPP1R13L |
protein phosphatase 1, regulatory subunit 13 like |
chr17_-_64225508 | 0.41 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr20_+_9049682 | 0.41 |
ENST00000334005.3 ENST00000378473.3 |
PLCB4 |
phospholipase C, beta 4 |
chr8_+_128748466 | 0.41 |
ENST00000524013.1 ENST00000520751.1 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
chr1_-_116383322 | 0.41 |
ENST00000429731.1 |
NHLH2 |
nescient helix loop helix 2 |
chr12_+_41831485 | 0.41 |
ENST00000539469.2 ENST00000298919.7 |
PDZRN4 |
PDZ domain containing ring finger 4 |
chr13_-_46756351 | 0.41 |
ENST00000323076.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr21_-_34186006 | 0.41 |
ENST00000490358.1 |
C21orf62 |
chromosome 21 open reading frame 62 |
chr2_-_208030647 | 0.41 |
ENST00000309446.6 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
chr8_+_128748308 | 0.41 |
ENST00000377970.2 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
chr3_+_171561127 | 0.40 |
ENST00000334567.5 ENST00000450693.1 |
TMEM212 |
transmembrane protein 212 |
chr10_+_123923205 | 0.40 |
ENST00000369004.3 ENST00000260733.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr12_-_71031220 | 0.40 |
ENST00000334414.6 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr7_+_142880512 | 0.40 |
ENST00000446620.1 |
TAS2R39 |
taste receptor, type 2, member 39 |
chr1_-_1356719 | 0.40 |
ENST00000520296.1 |
ANKRD65 |
ankyrin repeat domain 65 |
chrX_-_54070607 | 0.39 |
ENST00000338154.6 ENST00000338946.6 |
PHF8 |
PHD finger protein 8 |
chr6_+_135502466 | 0.39 |
ENST00000367814.4 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr21_-_40033618 | 0.39 |
ENST00000417133.2 ENST00000398910.1 ENST00000442448.1 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr14_-_36988882 | 0.39 |
ENST00000498187.2 |
NKX2-1 |
NK2 homeobox 1 |
chr3_-_168865522 | 0.39 |
ENST00000464456.1 |
MECOM |
MDS1 and EVI1 complex locus |
chrX_-_136113833 | 0.39 |
ENST00000298110.1 |
GPR101 |
G protein-coupled receptor 101 |
chr7_-_95951334 | 0.39 |
ENST00000265631.5 |
SLC25A13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
chrX_-_54824673 | 0.39 |
ENST00000218436.6 |
ITIH6 |
inter-alpha-trypsin inhibitor heavy chain family, member 6 |
chr1_-_1356628 | 0.38 |
ENST00000442470.1 ENST00000537107.1 |
ANKRD65 |
ankyrin repeat domain 65 |
chr1_+_239882842 | 0.38 |
ENST00000448020.1 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
chr9_-_33473882 | 0.38 |
ENST00000455041.2 ENST00000353159.2 ENST00000297990.4 ENST00000379471.2 |
NOL6 |
nucleolar protein 6 (RNA-associated) |
chr21_-_31588365 | 0.38 |
ENST00000399899.1 |
CLDN8 |
claudin 8 |
chr11_-_34535332 | 0.38 |
ENST00000257832.2 ENST00000429939.2 |
ELF5 |
E74-like factor 5 (ets domain transcription factor) |
chr6_+_135502408 | 0.38 |
ENST00000341911.5 ENST00000442647.2 ENST00000316528.8 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr2_+_42104692 | 0.38 |
ENST00000398796.2 ENST00000442214.1 |
AC104654.1 |
AC104654.1 |
chr14_+_56127989 | 0.38 |
ENST00000555573.1 |
KTN1 |
kinectin 1 (kinesin receptor) |
chr6_-_31550192 | 0.38 |
ENST00000429299.2 ENST00000446745.2 |
LTB |
lymphotoxin beta (TNF superfamily, member 3) |
chr21_-_31588338 | 0.37 |
ENST00000286809.1 |
CLDN8 |
claudin 8 |
chr4_-_153303658 | 0.37 |
ENST00000296555.5 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr6_+_135502501 | 0.37 |
ENST00000527615.1 ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr9_-_14722715 | 0.37 |
ENST00000380911.3 |
CER1 |
cerberus 1, DAN family BMP antagonist |
chr8_-_28243590 | 0.36 |
ENST00000523095.1 ENST00000522795.1 |
ZNF395 |
zinc finger protein 395 |
chr10_+_23728198 | 0.36 |
ENST00000376495.3 |
OTUD1 |
OTU domain containing 1 |
chr4_-_74486347 | 0.36 |
ENST00000342081.3 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr7_-_95951310 | 0.36 |
ENST00000542654.1 |
SLC25A13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
chr8_-_95449155 | 0.36 |
ENST00000481490.2 |
FSBP |
fibrinogen silencer binding protein |
chr17_+_72427477 | 0.36 |
ENST00000342648.5 ENST00000481232.1 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr6_+_106546808 | 0.36 |
ENST00000369089.3 |
PRDM1 |
PR domain containing 1, with ZNF domain |
chr1_+_196743912 | 0.36 |
ENST00000367425.4 |
CFHR3 |
complement factor H-related 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 5.9 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.4 | 1.1 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 1.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 1.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 2.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.3 | 1.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.8 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.2 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 2.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 1.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 5.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.6 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 0.9 | GO:1902617 | response to fluoride(GO:1902617) |
0.2 | 0.5 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.3 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.2 | 1.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.4 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 3.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.3 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) histone H3-K27 demethylation(GO:0071557) |
0.1 | 2.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 1.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.5 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.3 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.1 | 0.5 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.6 | GO:1903899 | lung goblet cell differentiation(GO:0060480) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 0.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.8 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.3 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 1.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 1.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 3.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 1.3 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.1 | 1.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.1 | 0.2 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.2 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.1 | 0.3 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.0 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.2 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.0 | 1.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.3 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 5.0 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.2 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.1 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.3 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.0 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.2 | GO:0021902 | amygdala development(GO:0021764) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.2 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 4.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.7 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.1 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.0 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.4 | GO:0019751 | polyol metabolic process(GO:0019751) inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) allantois development(GO:1905069) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0035993 | pulmonary myocardium development(GO:0003350) subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) short-term synaptic potentiation(GO:1990926) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.5 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 1.9 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 1.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 1.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 5.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 2.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 2.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.1 | GO:0042575 | zeta DNA polymerase complex(GO:0016035) DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.0 | 1.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 2.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 6.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 2.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 1.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.0 | 1.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 2.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 2.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.1 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.3 | 1.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 0.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 0.8 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.3 | 0.8 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.2 | 2.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 0.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 5.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.5 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 2.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.1 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 2.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 3.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 1.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 1.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 1.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 1.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 4.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 5.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 3.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 3.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 4.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 5.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 3.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |